Phillip McClellan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Phillip McClellan has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Ozan Akkus
Department of Mechanical and Aerospace Engineering Case Western Reserve University Cleveland Ohio USA
4 shared publications - Ilaha Isali
Department of Urology, Weill Cornell Medicine, New York, NY, USA
3 shared publications - Joo Hee Choi
Department of Mechanical and Aerospace Engineering Case Western Reserve University Cleveland Ohio USA
3 shared publications Ozan Akkus
Department of Mechanical and Aerospace Engineering Case Western Reserve University Cleveland Ohio USA
3 shared publications- Adonis Hijaz
University Hospitals Cleveland Medical Center, Cleveland, OH 44145, USA
2 shared publications - Ahmad Osama Khalifa
Department of Urology, Freeman Hospital, Newcastle NE7 7PJ, UK
2 shared publications
Latest Publications
- 22 September 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (9) , e70154
In Vivo Assessment of a Load‐Bearing Biphasic Osteotendinous Braided Collagen Scaffold for Reconstruction of Massive Irreparable Rotator Cuff Defects
Massive, irreparable rotator cuff tears affect a significant patient population and often require invasive procedures such as allograft patch augmentation, superior capsule reconstruction, and muscle transfers due to the limited regenerative capacity and inability to reattach the rotator cuff to the humerus. Current surgical techniques primarily focus on mechanically reinforcing the tendon without promoting biological integration, leading to high re‐tear rates and functional limitations. This study aimed to evaluate OsTend, a biphasic osteotendinous scaffold designed to span the MIRC defect by bridging the muscle to the bone footprint. As such, OsTend is designed to be conducive to supporting tendon and bone regeneration while enabling muscle tissue ingrowth. OsTend consists of electrochemically aligned collagen threads braided into a three‐region scaffold: a proximal region for muscle integration, a midsection as a tendon regeneration template along with a polycaprolactone membrane as a suture rip‐stop, and a hydroxyapatite‐infused distal region to facilitate bone ingrowth. A total of 16 New Zealand White rabbits underwent unilateral infraspinatus tendon resection and repair with OsTend, followed by biomechanical testing, micro‐computed tomography, and histological analysis at 1 and 3 months postimplantation. Results demonstrated a 65% increase in ultimate tensile strength from 1 month (102.1 ± 21.5 N) to 3 months (167.9 ± 62.3 N). Tendon retraction between 1 month (7.47 ± 2.61 mm) and 3 months (6.77 ± 1.91 mm) was < 2 mm during the study period. Bone volume fraction at 1 month (24.80% ± 8.30%) and 3 months (21.52% ± 4.97%) of the footprint reached approximately 75% of the intact bone (30%). Between 1 and 3 months, the failure mode of repaired shoulders shifted from pullout at the enthesis (80% at 1 month) to rupture at the mid‐substance (100% at 3 months), indicating attainment of a functional integration between bone and scaffold over time. Histological analysis revealed collagen fiber alignment in the muscle and tendon regions and bone‐like tissue formation surrounding the hydroxyapatite‐infused region. These findings suggest that OsTend reestablishes tendon–bone attachment with structural integrity; thus, this multiphasic biotextile platform holds the potential as an off‐the‐shelf biomaterial for treating massive irreparable rotator cuff tears.
- 22 September 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (9) , e70154
In Vivo Assessment of a Load‐Bearing Biphasic Osteotendinous Braided Collagen Scaffold for Reconstruction of Massive Irreparable Rotator Cuff Defects
Massive, irreparable rotator cuff tears affect a significant patient population and often require invasive procedures such as allograft patch augmentation, superior capsule reconstruction, and muscle transfers due to the limited regenerative capacity and inability to reattach the rotator cuff to the humerus. Current surgical techniques primarily focus on mechanically reinforcing the tendon without promoting biological integration, leading to high re‐tear rates and functional limitations. This study aimed to evaluate OsTend, a biphasic osteotendinous scaffold designed to span the MIRC defect by bridging the muscle to the bone footprint. As such, OsTend is designed to be conducive to supporting tendon and bone regeneration while enabling muscle tissue ingrowth. OsTend consists of electrochemically aligned collagen threads braided into a three‐region scaffold: a proximal region for muscle integration, a midsection as a tendon regeneration template along with a polycaprolactone membrane as a suture rip‐stop, and a hydroxyapatite‐infused distal region to facilitate bone ingrowth. A total of 16 New Zealand White rabbits underwent unilateral infraspinatus tendon resection and repair with OsTend, followed by biomechanical testing, micro‐computed tomography, and histological analysis at 1 and 3 months postimplantation. Results demonstrated a 65% increase in ultimate tensile strength from 1 month (102.1 ± 21.5 N) to 3 months (167.9 ± 62.3 N). Tendon retraction between 1 month (7.47 ± 2.61 mm) and 3 months (6.77 ± 1.91 mm) was < 2 mm during the study period. Bone volume fraction at 1 month (24.80% ± 8.30%) and 3 months (21.52% ± 4.97%) of the footprint reached approximately 75% of the intact bone (30%). Between 1 and 3 months, the failure mode of repaired shoulders shifted from pullout at the enthesis (80% at 1 month) to rupture at the mid‐substance (100% at 3 months), indicating attainment of a functional integration between bone and scaffold over time. Histological analysis revealed collagen fiber alignment in the muscle and tendon regions and bone‐like tissue formation surrounding the hydroxyapatite‐infused region. These findings suggest that OsTend reestablishes tendon–bone attachment with structural integrity; thus, this multiphasic biotextile platform holds the potential as an off‐the‐shelf biomaterial for treating massive irreparable rotator cuff tears.
- Open Access
- 6 August 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (8)
In Vivo Response to Electrocompacted Tendon‐Derived Thread Scaffolds During Tendon Repair
Tendon injuries remain a major clinical challenge due to the tissue's limited regenerative capacity and poor remodeling of current allograft‐based therapies. To address these limitations, we developed a tendon‐derived thread (TDT) scaffold by electrocompacting decellularized tendon powder into aligned threads, which were subsequently woven into a porous overlay patch. Biochemical analyses of TDT confirmed efficient decellularization (DNA < 50 ng/mg) and the preservation of collagen and proteoglycans. Compared to en bloc human tendon graft (HTG), the TDT scaffold exhibited significantly higher swelling ratios and greater weight loss over 8 weeks in vitro, indicating greater porosity and faster degradation. In a rabbit infraspinatus partial‐thickness fenestration injury model, the TDT scaffold and HTG were sutured over the injury and evaluated at 2 and 8 weeks to observe tissue infiltration and in vivo response to biomaterial degradation during early phases of healing. Biomechanical testing of shoulders showed no significant differences in load relaxation, ultimate tensile strength, and stiffness among intact, HTG, and TDT scaffold groups in this injury model, suggesting comparable mechanical restoration. Histological and gross observations indicated progressive resorption of TDT scaffolds, which were infiltrated by cells at 2 weeks, and neotissue formation was evident by 8 weeks. In contrast, cell infiltration into the allograft was limited at both time points, and there was no evidence of degradation in vivo. These findings support the potential of the TDT scaffold as a degradable scaffold to support tendon healing during injury.
- 6 August 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (8)
Open AccessIn Vivo Response to Electrocompacted Tendon‐Derived Thread Scaffolds During Tendon Repair
Tendon injuries remain a major clinical challenge due to the tissue's limited regenerative capacity and poor remodeling of current allograft‐based therapies. To address these limitations, we developed a tendon‐derived thread (TDT) scaffold by electrocompacting decellularized tendon powder into aligned threads, which were subsequently woven into a porous overlay patch. Biochemical analyses of TDT confirmed efficient decellularization (DNA < 50 ng/mg) and the preservation of collagen and proteoglycans. Compared to en bloc human tendon graft (HTG), the TDT scaffold exhibited significantly higher swelling ratios and greater weight loss over 8 weeks in vitro, indicating greater porosity and faster degradation. In a rabbit infraspinatus partial‐thickness fenestration injury model, the TDT scaffold and HTG were sutured over the injury and evaluated at 2 and 8 weeks to observe tissue infiltration and in vivo response to biomaterial degradation during early phases of healing. Biomechanical testing of shoulders showed no significant differences in load relaxation, ultimate tensile strength, and stiffness among intact, HTG, and TDT scaffold groups in this injury model, suggesting comparable mechanical restoration. Histological and gross observations indicated progressive resorption of TDT scaffolds, which were infiltrated by cells at 2 weeks, and neotissue formation was evident by 8 weeks. In contrast, cell infiltration into the allograft was limited at both time points, and there was no evidence of degradation in vivo. These findings support the potential of the TDT scaffold as a degradable scaffold to support tendon healing during injury.
- Open Access
- 16 June 2025
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 113 (6) , e37948
Tendon‐Tissue Derived Monofilaments by Electrochemical Compaction: Production and Characterization
Repair of tendon tissues remains a complex problem in orthopedic surgery. Tendon auto‐ and allografts are not utilized to the full extent of their capabilities due largely to the lack of porosity and availability of properly processed tendon stock. Cryomilling is often utilized to maximize surface area‐to‐volume while limiting alterations to native protein/gene structure. In this study, native tendons were isolated, cryomilled, and decellularized using a truncated protocol. The resulting decellularized tendon powder exhibited reduced DNA content of less than 15 ng/mg, indicating effective removal of cellular components. The resulting decellularized tendon “powder” was then subjected to mild acidic conditions to partially solubilize the collagen within the extracellular matrix to produce a solution that could be electrochemically compacted to generate aligned fibers. Proteomic analyses revealed the presence of tendon‐related proteins (cartilage oligomeric protein, fibromodulin, lumican, biglycan, and tenascin c). Proteoglycans were present in tendon‐derived thread (TDT) and largely absent in pure collagen threads, as visualized by safranin O and quantified by dimethylmethylene blue staining. Mesenchymal stem cells seeded and cultured for up to 14 days on collagen threads and TDTs exhibited similar expression of genes related to tendon tissue.
- 16 June 2025
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 113 (6) , e37948
Open AccessTendon‐Tissue Derived Monofilaments by Electrochemical Compaction: Production and Characterization
Repair of tendon tissues remains a complex problem in orthopedic surgery. Tendon auto‐ and allografts are not utilized to the full extent of their capabilities due largely to the lack of porosity and availability of properly processed tendon stock. Cryomilling is often utilized to maximize surface area‐to‐volume while limiting alterations to native protein/gene structure. In this study, native tendons were isolated, cryomilled, and decellularized using a truncated protocol. The resulting decellularized tendon powder exhibited reduced DNA content of less than 15 ng/mg, indicating effective removal of cellular components. The resulting decellularized tendon “powder” was then subjected to mild acidic conditions to partially solubilize the collagen within the extracellular matrix to produce a solution that could be electrochemically compacted to generate aligned fibers. Proteomic analyses revealed the presence of tendon‐related proteins (cartilage oligomeric protein, fibromodulin, lumican, biglycan, and tenascin c). Proteoglycans were present in tendon‐derived thread (TDT) and largely absent in pure collagen threads, as visualized by safranin O and quantified by dimethylmethylene blue staining. Mesenchymal stem cells seeded and cultured for up to 14 days on collagen threads and TDTs exhibited similar expression of genes related to tendon tissue.
- Open Access
- 18 September 2024
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 113 (1)
Differential effects of macrophage subtype‐specific cytokines on fibroblast proliferation and endothelial cell function in co‐culture system
Macrophages are involved in several critical activities associated with tissue repair and regeneration. Current approaches in regenerative medicine are focusing on leveraging the innate immune response to accelerate tissue regeneration and improve long‐term healing outcomes. Of particular interest in this regard are the currently known, four main M2 macrophage subtypes: M2interleukin (IL)‐4,IL‐13, M2IC, M2IL‐10, M2non‐selective adenosine receptor agonists (NECA) (M2IL‐4,IL‐13 → M2NECA). In this study, rat bone marrow‐derived macrophages (M0) were polarized to each of the four subtypes M2IL‐4,IL‐13 → M2NECA and cultured for 72 h in vitro. Luminex assay results highlighted increased production of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for M2IL‐4,IL‐13, higher amounts of transforming growth factor‐beta 1 (TGF‐β1) for M2IL‐10, and elevated vascular endothelial growth factor A (VEGF‐A) from M2NECA. Co‐culture experiments performed with M2IL‐10 macrophages and L929 fibroblasts highlighted the increased production of soluble collagen within the media as well as higher amounts of collagen in the extracellular matrix. Human umbilical vein endothelial cells (HUVECs) were co‐cultured with M2NECA macrophages, which demonstrated an increase in intercellular adhesion molecule (ICAM) and platelet endothelial cell adhesion molecule (PECAM), as well as increased formation of endothelial tubes. The findings of this study emphasize a critical demand for further characterization and analyses of distinct M2 subtypes and careful selection of specific macrophage populations for regeneration of specific tissue types. The current, broad classification of “M2” may be sufficient in many general tissue engineering applications, but, as conditions are constantly in flux within the microenvironment in vivo, a higher degree of specificity and control over the initial M2 subtype could result in more consistent long‐term outcomes where macrophages are utilized as part of an overall regenerative strategy.
- 18 September 2024
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 113 (1)
Open AccessDifferential effects of macrophage subtype‐specific cytokines on fibroblast proliferation and endothelial cell function in co‐culture system
Macrophages are involved in several critical activities associated with tissue repair and regeneration. Current approaches in regenerative medicine are focusing on leveraging the innate immune response to accelerate tissue regeneration and improve long‐term healing outcomes. Of particular interest in this regard are the currently known, four main M2 macrophage subtypes: M2interleukin (IL)‐4,IL‐13, M2IC, M2IL‐10, M2non‐selective adenosine receptor agonists (NECA) (M2IL‐4,IL‐13 → M2NECA). In this study, rat bone marrow‐derived macrophages (M0) were polarized to each of the four subtypes M2IL‐4,IL‐13 → M2NECA and cultured for 72 h in vitro. Luminex assay results highlighted increased production of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for M2IL‐4,IL‐13, higher amounts of transforming growth factor‐beta 1 (TGF‐β1) for M2IL‐10, and elevated vascular endothelial growth factor A (VEGF‐A) from M2NECA. Co‐culture experiments performed with M2IL‐10 macrophages and L929 fibroblasts highlighted the increased production of soluble collagen within the media as well as higher amounts of collagen in the extracellular matrix. Human umbilical vein endothelial cells (HUVECs) were co‐cultured with M2NECA macrophages, which demonstrated an increase in intercellular adhesion molecule (ICAM) and platelet endothelial cell adhesion molecule (PECAM), as well as increased formation of endothelial tubes. The findings of this study emphasize a critical demand for further characterization and analyses of distinct M2 subtypes and careful selection of specific macrophage populations for regeneration of specific tissue types. The current, broad classification of “M2” may be sufficient in many general tissue engineering applications, but, as conditions are constantly in flux within the microenvironment in vivo, a higher degree of specificity and control over the initial M2 subtype could result in more consistent long‐term outcomes where macrophages are utilized as part of an overall regenerative strategy.
- 10 January 2024
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 112 (5) , 781-792
Dexamethasone eluting polydopaminated polycaprolactone‐poly (lactic‐co‐glycolic) acid for treatment of tracheal stenosis
Tracheal stenosis is commonly caused by injury, resulting in inflammation and fibrosis. Inhibiting inflammation and promoting epithelization can reduce recurrence after initial successful treatment of tracheal stenosis. Steroids play an important role in tracheal stenosis management. This study in vitro evaluated effectiveness of a polydopaminated polycaprolactone stent coated with dexamethasone‐eluting poly(lactic‐co‐glycolic) acid microparticles (μPLGA) for tracheal stenosis management. Polydopamination was characterized by Raman spectroscopy and promoted epithelialization while dexamethasone delivery reduced macrophage activity, assessed by individual cell area measurements and immunofluorescent staining for inducible nitric oxide synthase (iNOS). Dexamethasone release was quantified by high‐performance liquid chromatography over 30 days. Activation‐related increase in cell area and iNOS production by RAW 264.7 were both reduced significantly (p < .05) through dexamethasone release. Epithelial cell spreading was higher on polydopaminated polycaprolactone (PCL) than PCL‐alone (p < .05). Force required for stent migration was measured by pullout tests of PCL‐μPLGA stents from cadaveric rabbit and porcine tracheas (0.425 ± 0.068 N and 1.082 ± 0.064 N, respectively) were above forces estimated to occur during forced respiration. Biomechanical support provided by stents to prevent airway collapse was assessed by comparing compressive circumferential stiffness, and stiffness of the stent was about 1/10th of the rabbit trachea (0.156 ± 0.023 N/mm vs. 1.420 ± 0.194 N/mm, respectively). A dexamethasone‐loaded PCL‐μPLGA stent platform can deliver dexamethasone and exhibits sufficient mechanical properties to anchor within the trachea and polydopamination of PCL is conducive to epithelial layer formation. Therefore, a polydopaminated PCL‐μPLGA stent is a promising candidate for in vivo evaluation for treatment of tracheal restenosis.
- 10 January 2024
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 112 (5) , 781-792
Dexamethasone eluting polydopaminated polycaprolactone‐poly (lactic‐co‐glycolic) acid for treatment of tracheal stenosis
Tracheal stenosis is commonly caused by injury, resulting in inflammation and fibrosis. Inhibiting inflammation and promoting epithelization can reduce recurrence after initial successful treatment of tracheal stenosis. Steroids play an important role in tracheal stenosis management. This study in vitro evaluated effectiveness of a polydopaminated polycaprolactone stent coated with dexamethasone‐eluting poly(lactic‐co‐glycolic) acid microparticles (μPLGA) for tracheal stenosis management. Polydopamination was characterized by Raman spectroscopy and promoted epithelialization while dexamethasone delivery reduced macrophage activity, assessed by individual cell area measurements and immunofluorescent staining for inducible nitric oxide synthase (iNOS). Dexamethasone release was quantified by high‐performance liquid chromatography over 30 days. Activation‐related increase in cell area and iNOS production by RAW 264.7 were both reduced significantly (p < .05) through dexamethasone release. Epithelial cell spreading was higher on polydopaminated polycaprolactone (PCL) than PCL‐alone (p < .05). Force required for stent migration was measured by pullout tests of PCL‐μPLGA stents from cadaveric rabbit and porcine tracheas (0.425 ± 0.068 N and 1.082 ± 0.064 N, respectively) were above forces estimated to occur during forced respiration. Biomechanical support provided by stents to prevent airway collapse was assessed by comparing compressive circumferential stiffness, and stiffness of the stent was about 1/10th of the rabbit trachea (0.156 ± 0.023 N/mm vs. 1.420 ± 0.194 N/mm, respectively). A dexamethasone‐loaded PCL‐μPLGA stent platform can deliver dexamethasone and exhibits sufficient mechanical properties to anchor within the trachea and polydopamination of PCL is conducive to epithelial layer formation. Therefore, a polydopaminated PCL‐μPLGA stent is a promising candidate for in vivo evaluation for treatment of tracheal restenosis.
- 3 August 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 18 (5) , 629-641
A systematic review of underlying genetic factors associated with ureteropelvic junction obstruction in stenotic human tissue
- 3 August 2022
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 18 (5) , 629-641
A systematic review of underlying genetic factors associated with ureteropelvic junction obstruction in stenotic human tissue
- 25 February 2022
- Published by S. Karger AG in Urologia Internationalis
- Vol. 107 (4) , 422-428
Comparison of Morphological and Histological Characteristics of Human and Sheep: Sheep as a Potential Model for Testing Midurethral Slings in vivo
Introduction: The sheep was evaluated as a potential model for preclinical evaluation of urethral slings in vivo based on: (1) anatomical measurements of the sheep vagina and (2) histological tissue integration and host response to polypropylene (PP) slings. Methods: Eight female, multiparous sheep were utilized. Three of 8 animals underwent surgery mimicking human tension-free vaginal tape protocols for midurethral slings and were euthanized at 6 months. The following measurements were obtained: vaginal length, maximum vaginal width with retraction, symphysis pubis length, and distance from the pubic bone to incision. Explanted sling samples from sheep and human were stained with hematoxylin and eosin for host reaction assessment. Results: Geometric measurements were similar between humans and sheep. Sheep vaginal anatomy allowed sling placement similar to procedures in human surgeries, and all sheep recovered without problems. Comparative histology between the sheep and human indicated similar host reaction and collagen deposition around implants, confirming suitability of the sheep model for biomaterial response assessment. Conclusion: Sheep vaginal length is comparable to humans. Tissue integration and host response to PP slings showed chronic inflammation with rich collagen deposition around the material in both sheep and human specimens, highlighting the sheep as a potential animal model for preclinical testing of midurethral slings.
- 25 February 2022
- Published by S. Karger AG in Urologia Internationalis
- Vol. 107 (4) , 422-428
Comparison of Morphological and Histological Characteristics of Human and Sheep: Sheep as a Potential Model for Testing Midurethral Slings in vivo
Introduction: The sheep was evaluated as a potential model for preclinical evaluation of urethral slings in vivo based on: (1) anatomical measurements of the sheep vagina and (2) histological tissue integration and host response to polypropylene (PP) slings. Methods: Eight female, multiparous sheep were utilized. Three of 8 animals underwent surgery mimicking human tension-free vaginal tape protocols for midurethral slings and were euthanized at 6 months. The following measurements were obtained: vaginal length, maximum vaginal width with retraction, symphysis pubis length, and distance from the pubic bone to incision. Explanted sling samples from sheep and human were stained with hematoxylin and eosin for host reaction assessment. Results: Geometric measurements were similar between humans and sheep. Sheep vaginal anatomy allowed sling placement similar to procedures in human surgeries, and all sheep recovered without problems. Comparative histology between the sheep and human indicated similar host reaction and collagen deposition around implants, confirming suitability of the sheep model for biomaterial response assessment. Conclusion: Sheep vaginal length is comparable to humans. Tissue integration and host response to PP slings showed chronic inflammation with rich collagen deposition around the material in both sheep and human specimens, highlighting the sheep as a potential animal model for preclinical testing of midurethral slings.
- 15 January 2022
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (5) , 197.e11-197.e23
Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis
- 15 January 2022
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (5) , 197.e11-197.e23
Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis
- Open Access
- 13 June 2018
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 107 (3) , 479-489
In vivo biocompatibility and time‐dependent changes in mechanical properties of woven collagen meshes: A comparison to xenograft and synthetic mid‐urethral sling materials
Meshes woven from highly aligned collagen threads crosslinked using either genipin or 1‐ethyl‐3‐(3‐dimethylaminopropyl) carboiimide and N‐hydroxy succinimide (EDC/NHS) were implanted in a subcutaneous rat model to evaluate their biocompatibility (at 2 weeks, 2 months, and 5 months), mechanical properties (at baseline, 2 months, and 5 months) and ultimately their suitability for use as mid‐urethral slings (MUS) for management of stress urinary incontinence. Porcine dermal (Xenmatrix) and monofilament polypropylene (Prolene) meshes were also implanted to provide comparison to clinically used materials. Quantitative histological scoring showed tissue integration in Xenmatrix was almost absent, while the open network of woven collagen and Prolene meshes allowed for cellular and tissue integration. However, strength and stiffness of genipin‐crosslinked collagen (GCC), Prolene, and Xenmatrix meshes were not significantly different from those of native rectus fascia and vaginal tissues of animals at 5 months. EDC/NHS‐crosslinked collagen (ECC) meshes were degraded so extensively at five months that samples could only be used for histological staining. Picrosirius red and Masson's trichrome staining revealed that integrated tissue within GCC meshes was more aligned (p = 0.02) and appeared more concentrated than ECC meshes at 5 months. Furthermore, immunohistochemical staining showed that GCC meshes attracted a greater number of cells expressing markers for M2 macrophages, those associated with regeneration, than ECC meshes (p = 0.01 for CD206+ cells, p = 0.001 CD163+ cells) at 5 months. As such, GCC meshes hold promise as a new MUS biomaterial based on favorable induction of fibrous tissue resulting in mechanical stiffness matching that of native tissue. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2018. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 479–489, 2019.
- 13 June 2018
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 107 (3) , 479-489
Open AccessIn vivo biocompatibility and time‐dependent changes in mechanical properties of woven collagen meshes: A comparison to xenograft and synthetic mid‐urethral sling materials
Meshes woven from highly aligned collagen threads crosslinked using either genipin or 1‐ethyl‐3‐(3‐dimethylaminopropyl) carboiimide and N‐hydroxy succinimide (EDC/NHS) were implanted in a subcutaneous rat model to evaluate their biocompatibility (at 2 weeks, 2 months, and 5 months), mechanical properties (at baseline, 2 months, and 5 months) and ultimately their suitability for use as mid‐urethral slings (MUS) for management of stress urinary incontinence. Porcine dermal (Xenmatrix) and monofilament polypropylene (Prolene) meshes were also implanted to provide comparison to clinically used materials. Quantitative histological scoring showed tissue integration in Xenmatrix was almost absent, while the open network of woven collagen and Prolene meshes allowed for cellular and tissue integration. However, strength and stiffness of genipin‐crosslinked collagen (GCC), Prolene, and Xenmatrix meshes were not significantly different from those of native rectus fascia and vaginal tissues of animals at 5 months. EDC/NHS‐crosslinked collagen (ECC) meshes were degraded so extensively at five months that samples could only be used for histological staining. Picrosirius red and Masson's trichrome staining revealed that integrated tissue within GCC meshes was more aligned (p = 0.02) and appeared more concentrated than ECC meshes at 5 months. Furthermore, immunohistochemical staining showed that GCC meshes attracted a greater number of cells expressing markers for M2 macrophages, those associated with regeneration, than ECC meshes (p = 0.01 for CD206+ cells, p = 0.001 CD163+ cells) at 5 months. As such, GCC meshes hold promise as a new MUS biomaterial based on favorable induction of fibrous tissue resulting in mechanical stiffness matching that of native tissue. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2018. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 479–489, 2019.